FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis in Men
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)

Snippet

SUPPL AP for FOSAMAX (ALENDRONATE SODIUM)